1-3 of 3
Brinda Tammara
Close
Sort by
Journal Articles

A randomized clinical trial of the efficacy and safety of rivipansel for sickle cell vaso-occlusive crisis

Clinical Trials & Observations
Carlton D. Dampier, Marilyn Jo Telen, Ted Wun, R. Clark Brown, Payal Desai, Fuad El Rassi, Beng Fuh, Julie Kanter, Yves Pastore, Jennifer Rothman, James G. Taylor, VI, David Readett, Krupa M. Sivamurthy, Brinda Tammara, Li-Jung Tseng, Jay Nelson Lozier, Helen Thackray, John L. Magnani, Kathryn L. Hassell
Journal: Blood
Blood (2023) 141 (2): 168–179.
https://doi.org/10.1182/blood.2022015797
Published: 2023
Includes: Supplemental data
Journal Articles

Dose Selection Process for Younger Children Participating in a Phase 3 Study to Evaluate the Efficacy and Safety of Rivipansel (GMI-1070) in the Treatment of Vaso-Occlusive Crisis in Hospitalized Patients with Sickle Cell Disease

Brinda Tammara, PhD, Frank E. Shafer, MD, Lutz Harnisch, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3643.
https://doi.org/10.1182/blood-2018-99-117550
Published: 2018
Journal Articles

Effect of Renal Impairment on the Pharmacokinetics and Safety of Rivipansel in Subjects with Renal Impairment and in Healthy Subjects

Brinda Tammara, PhD, Kelly Ryan, Anna Plotka, Frank E. Shafer, MD, Hua Wei, David Readett, Annie Fang, Joan Korth-Bradley, PharmD, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1083.
https://doi.org/10.1182/blood-2018-99-111926
Published: 2018